Skip to content

Screening for Ovarian granulosa cell markers and experienced prescription of Chinese medicine (Jing Fang) in the treatment of PCOS

Screening for Ovarian granulosa cell markers and experienced prescription of Chinese medicine (Jing Fang) in the treatment of PCOS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018597
Enrollment
Unknown
Registered
2018-09-26
Start date
2018-09-30
Completion date
Unknown
Last updated
2018-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome, PCOS

Interventions

Group 2:Chinese medicine Cang-fu-dao-tan Pill
Non phlegm and dampness patients control, not randomized allocation:Nil

Sponsors

Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Compliance with the diagnostic criteria of PCOS infertility; Conforming to the standard of syndrome differentiation of phlegm and dampness in traditional Chinese medicine; Signature of an informed consent.

Exclusion criteria

Exclusion criteria: Has serious heart, liver, kidney disease, blood system pathological change or malignant tumor, etc.;Participants who are participating in or who have participated in other clinical trials within a month; Subjects who had been treated with estrogen or drugs containing estrogen in the first three months of the group;Persons with mental illness;Persons known to be allergic to such drugs and allergens.

Design outcomes

Primary

MeasureTime frame
DNA methylation;

Countries

China

Contacts

Public ContactFang Lian

Shandong University of Traditional Chinese Medicine

1066870368@qq.com+86 13706403122

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026